News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News Roche's Mabthera faces cut-price competition in EU Blockbuster likely to face cheap near-copy for first time.
News Lilly and Boehringer biosimilar undercuts Lantus by 15% Sanofi under pressure following long-awaited biosimilar launch.
News Embattled Mylan files Herceptin biosimilar in US But senators call for investigation into EpiPen schools contracts.
News CHMP backs Novo's haemophilia A drug Frehemgo Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
